ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves First Treatment for Episodic Cluster Headache to Reduce Frequency
June 06, 2019The U.S. Food and Drug Administration (FDA) approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. -
Mixed trial results for Lilly’s headache drug galcanezumab
July 13, 2018Lilly has reported mixed trial data for its experimental therapy galcanezumab, showing efficacy in patients with episodic cluster headaches but failing in those with chronic cluster headache.
Pharma Sources Insight January 2025
